Liudmila Filipava | Environmental economics | Best Researcher Award

Dr. Liudmila Filipava | Environmental economics | Best Researcher Award

Associate Professor | Belarusian State University | Belarus

Liudmila Filipava is an accomplished academic specializing in international economics and public-private partnerships. Currently serving as an Associate Professor in the International Economic Relations department at Belarusian State University (BSU), she teaches courses on global economic relations, foreign economic policy, and Eurasian economic integration. With a strong foundation in research, her work emphasizes the intersection of public and private sector partnerships in global economic development. Over the years, she has contributed significantly to academia, mentoring graduate and doctoral students while engaging in various international collaborations.

Profile

Orcid

Education:

Liudmila Filipava holds a PhD in Economics from Belarusian State Economic University (BSEU), earned in 2017. Her doctoral thesis focused on the role of public-private partnerships in international project implementation. Prior to this, she completed her Master’s degree in International Economics at BSEU in 2010, exploring strategies for attracting foreign direct investment into Belarus. She also holds a Bachelor’s degree in Economics from the same university, with a thesis on project finance. Additionally, Filipava pursued postgraduate studies and professional retraining, strengthening her pedagogical and research capabilities.

Experience:

Throughout her career, Filipava has held various prestigious academic positions. She is currently an Associate Professor at BSU, where she leads graduate and master’s level courses on world economics and foreign economic policy. Prior to this, she served as an Assistant Professor at the Academy of Public Administration under the President of the Republic of Belarus, and also at the Belarusian State University’s School of Business. In these roles, she contributed to the development of curricula and supervised numerous graduate and doctoral theses. Her professional journey also includes academic roles at the Belarusian National Technical University and Belarusian State Economic University.

Research Interests:

Filipava’s research interests lie primarily in international economics, with a focus on public-private partnerships, green economy development, and sustainable finance. Her work on the socio-economic impacts of transport investments, as well as the financing instruments for green economy transitions, underscores her commitment to addressing global challenges. Filipava has also contributed to the study of economic integration and foreign direct investment strategies, particularly within the context of the Belarusian economy. She is particularly interested in the regulatory frameworks of PPPs and their role in advancing sustainable development.

Awards:

Liudmila Filipava has been recognized for her academic excellence and leadership. In 2021, she was nominated for the prestigious International Qualifications Recognition Statement by World Educational Services (USA) for her doctoral achievements. Additionally, her contributions to the field of public-private partnerships earned her multiple professional training opportunities, such as those with the European Investment Bank Group and JVI Vienna. Her work on green economy financing has been widely appreciated within academic circles.

Publications:

Liudmila Filipava has authored numerous publications, with seven key works featured in prominent journals and books. Notable among these are:

  1. 2024: “Does Climate Change Increase Global Economic Gap? Empirical Evidence.” Journal of Poverty. [DOI: 10.1080/10875549.2024.2443741] (Scopus Q2)
  2. 2024: “Green Development Prospects of Fossil Fuel Export-Dependent Countries: A Case Study of the Caspian Sea Region.” Climate Change and Finance: Navigating the Challenges and Opportunities in Capital Markets. Springer. [DOI: 10.1007/978-3-031-56419-2_6]
  3. 2023: “Socio-Economic Impact Assessment of Transport Investments: A Case Study of an M-10 Highway.” International Journal of Transport Economics. [DOI: 10.19272/202306704004] (Scopus Q4)
  4. 2023: “The Development of the Global Green Finance Market: The Role of Banks and Non-banking Institutional Investors.” Green Finance Instruments, Fintech, and Investment Strategies. Springer. [DOI: 10.1007/978-3-031-29031-2_2]
  5. 2020: “Green Economy Financing Instruments.” Socio Economic Problems of Sustainable Development. UNEC Publishing.
  6. 2019: “Integration Potential Implementation Models.” Socio Economic Problems of Sustainable Development. Varazdin Development and Entrepreneurship Agency.
  7. 2019: “Public-Private Partnership: Theory and Practice.” Academy of Public Administration Publishing.

These works contribute to ongoing discussions in green finance, public-private partnerships, and international economic integration.

Conclusion:

Liudmila Filipava’s contributions to the field of economics, particularly in the areas of public-private partnerships and sustainable development, are significant. With a rich background in both academia and research, she has become a leader in her field. Her work on the socio-economic impact of green financing and public-private partnerships provides valuable insights into the evolving landscape of global economics. Through her publications, teaching, and research projects, Filipava continues to shape the future of economic policies and sustainable development.

Anke van Engen | Policy | Best Researcher Award

Mrs. Anke van Engen | Policy | Best Researcher Award 

Managing Principal , IQVIA , Netherlands

Anke van Engen is an accomplished professional with over 20 years of experience in global health economics, outcomes research, and market access. As the Managing Principal at IQVIA Payer Evidence Solutions in Amsterdam, she is dedicated to maximizing the commercial success of life sciences products through integrated payer evidence strategies. Anke excels in building long-lasting client partnerships and is highly respected for her expertise and collaborative approach. She leads an international team of consultants, guiding them to success with her strategic planning and leadership skills.

Profile

Scopus

Strengths for the Award

  • Extensive Experience: Anke van Engen brings over 20 years of global experience in health economics, outcomes research, and market access. This depth of expertise makes her a formidable candidate for the award.
  • Proven Leadership: Her ability to lead international teams, manage significant P&L responsibilities, and develop innovative strategies has resulted in commercial successes for life sciences companies.
  • Innovation and Thought Leadership: Anke has led the development of key market access tools like the HTA Accelerator platform, demonstrating her capacity for innovation. Her numerous awards and published works further solidify her thought leadership in the field.
  • Client-Centric Approach: Known for building long-lasting partnerships and being a trusted advisor, she has a strong track record of delivering consistent results to clients.
  • Recognition in the Field: Anke’s participation in high-profile panels and her awards, including ISPOR Best Podium and Poster Awards, highlight her respect and recognition within the industry.

Areas for Improvement

  • Broader Academic Contributions: While Anke has published extensively and contributed to industry thought leadership, increasing her involvement in academic research or university collaborations could enhance her profile in the academic community.
  • Further Expansion of Strategic Influence: Expanding her strategic influence beyond Europe and into more global markets, especially emerging ones, could showcase her ability to adapt and innovate in diverse environments.

Anke van Engen is an accomplished professional with over 20 years of experience in global health economics, outcomes research, and market access. As the Managing Principal at IQVIA Payer Evidence Solutions in Amsterdam, she is dedicated to maximizing the commercial success of life sciences products through integrated payer evidence strategies. Anke excels in building long-lasting client partnerships and is highly respected for her expertise and collaborative approach. She leads an international team of consultants, guiding them to success with her strategic planning and leadership skills.

Education

MSc Chemistry from the University of Leiden, the Netherlands (1994-1999), specializing in Bio-organic Chemistry. Anke also pursued an internship in biochemistry at the Institute of Fundamental Sciences, Massey University, New Zealand. Additionally, she completed advanced training programs in strategic leadership and health economic evaluation from the International Institute for Management Development and the University of Oxford, respectively.


Experience

Managing Principal, IQVIA Payer Evidence Solutions (2023-present): Leading a cluster within the EMEA Real World Evidence Leadership Team, Anke shares P&L responsibility and spearheads the integration of evidence and EU HTA offerings.
Senior Principal, IQVIA Real World Solutions (2020-2023): Directed the development of EMEA-specific offerings and played a crucial role in go-to-market strategies and client partnerships.
Senior Principal, IQVIA Consulting Services (2017-2020): Partnered with pharmaceutical companies, led global HTA solutions, and provided strategic oversight.
Principal, Quintiles Advisory Services (2014-2017): Developed and marketed the flagship HTA Accelerator product and led HEOR/MA strategy and implementation projects.
Consulting Director, Quintiles Consulting (2012-2014): Managed strategy consulting projects for pharmaceutical and medical device companies across Europe, with a focus on market access and health economic modeling.


Research Interest

Health Economics & Market Access: Anke’s research interests focus on developing and implementing health economic models, market access strategies, and health technology assessment (HTA). She has contributed significantly to thought leadership in payer evidence strategy, emphasizing the importance of integrating payer insights for successful product launches.


Awards

Issue Panel Recognition: Anke’s issue panel “EU Joint Clinical Assessment – One for All and All for One?” was ranked as the top-attended session at ISPOR Europe 2023.
Best Innovation Award (2014): Won the Sharktank contest for best innovation and secured investment for the HTA Accelerator platform.
ISPOR Awards: Received multiple ISPOR Best Podium and Poster Awards for her contributions to understanding the complexity of HTA networks and for her health economic analysis work.


Publications

The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment (2024). Value Health (Accepted for publication).
Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials (2021). Value Health, 24(8):1118-25.
Call in the PROs: Giving Credence to the Patient’s Perspective in Healthcare Decision Making (2020). ISPOR Value & Outcomes Spotlight.
Use of Insertable Cardiac Monitors for the Detection of Atrial Fibrillation in Patients with Cryptogenic Stroke in the United States is Cost-effective (2019). Journal of Medical Economics.
How Can Payer Requirements Be Satisfied when Treatment Switching Occurs? (2016). ISPOR Value & Outcomes Spotlight.
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium difficile Infection in Ireland (2015). JHEOR, 2(2):192-206.
Cost-effectiveness of a Fixed-dose Combination of Solifenacin and Oral Controlled Adsorption System Formulation of Tamsulosin in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia (2015). BMC Urology, 15(1):41.

Conclusion

Anke van Engen is a highly suitable candidate for the Best Researcher Award. Her extensive experience, leadership, and innovative contributions to health economics and market access make her a strong contender. With a few strategic expansions in her academic involvement and global reach, she could further solidify her candidacy for such prestigious recognition.